163 related articles for article (PubMed ID: 9854570)
21. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.
Cross S; Wei JP; Kim S; Brams DM
J Surg Oncol; 2006 Dec; 94(8):678-82. PubMed ID: 17131414
[TBL] [Abstract][Full Text] [Related]
22. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
23. Unilateral lobectomy for Hurthle cell adenoma.
Wasvary H; Czako P; Poulik J; Lucas R
Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in well-differentiated thyroid carcinoma.
Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
[TBL] [Abstract][Full Text] [Related]
25. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer.
Kushchayeva Y; Duh QY; Kebebew E; D'Avanzo A; Clark OH
Am J Surg; 2008 Apr; 195(4):457-62. PubMed ID: 18070728
[TBL] [Abstract][Full Text] [Related]
26. Predicting outcome and directing therapy for papillary thyroid carcinoma.
Kim S; Wei JP; Braveman JM; Brams DM
Arch Surg; 2004 Apr; 139(4):390-4; discussion 393-4. PubMed ID: 15078706
[TBL] [Abstract][Full Text] [Related]
27. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
28. Long-term results in elderly patients with differentiated thyroid carcinoma.
Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
[TBL] [Abstract][Full Text] [Related]
29. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
Ghossein RA; Hiltzik DH; Carlson DL; Patel S; Shaha A; Shah JP; Tuttle RM; Singh B
Cancer; 2006 Apr; 106(8):1669-76. PubMed ID: 16534796
[TBL] [Abstract][Full Text] [Related]
31. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
32. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma.
Saadi H; Kleidermacher P; Esselstyn C
Surgery; 2001 Jul; 130(1):30-5. PubMed ID: 11436009
[TBL] [Abstract][Full Text] [Related]
33. [Thyroid carcinoma: evaluation of prognostic factors].
d'Annibale M; Piovanello P; Appetecchia M; Grauso F; Bruno PL; Perri P; Piarulli L
Chir Ital; 1999; 51(1):59-64. PubMed ID: 10514918
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer].
Nowak W; Szybiński P; Nowak K; Stachura J; Popiela T
Wiad Lek; 2004; 57(9-10):431-7. PubMed ID: 15765757
[TBL] [Abstract][Full Text] [Related]
35. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy?
McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A
Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931
[TBL] [Abstract][Full Text] [Related]
36. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
37. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma.
Dosen D; Turić M; Smalcelj J; Janusić R; Grgić MP; Separović V
Head Neck; 2003 Jul; 25(7):521-8. PubMed ID: 12808654
[TBL] [Abstract][Full Text] [Related]
38. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
[TBL] [Abstract][Full Text] [Related]
39. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients.
Goldstein NS; Czako P; Neill JS
Mod Pathol; 2000 Feb; 13(2):123-30. PubMed ID: 10697268
[TBL] [Abstract][Full Text] [Related]
40. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]